Rockland Trust’s Chemed CHE Stock Holding History

Rockland Trust’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$601K	–	286
2024 Q3	$601K	Hold	1,000	–	–	0.03%	174
2024 Q2	$543K	Buy	+1,000	New	+$573K	0.03%	196

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rockland Trust's CHE Position: Q4 2024 in Review

Rockland Trust sold out of Chemed (CHE) in Q4 2024, closing a stake of 1,000 shares — an estimated $601K sold.

Rockland Trust first reported a position in CHE in Q2 2024 and held it in 2 quarters. The position peaked at $601K in Q3 2024. 528 funds tracked by Wall St. Rank hold CHE as of Q4 2024.

Rockland Trust reported no remaining Chemed position as of Q4 2024 after selling out during the quarter.
Rockland Trust sold 1,000 Chemed shares in Q4 2024, an estimated $601K.
Rockland Trust first reported a position in Chemed in Q2 2024 and held it in 2 quarters.
Rockland Trust's Chemed position peaked at $601K in Q3 2024.
528 funds tracked by Wall St. Rank held Chemed as of Q4 2024.

Based on Rockland Trust's 13F filing for Q4 2024, filed 14 Jan 2025.